Department of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain.
Immunology Department, Hospital Universitario La Princesa IIS-IP, Madrid, Spain.
J Leukoc Biol. 2022 Aug;112(2):339-346. doi: 10.1002/JLB.4COVCRA0721-356RRR. Epub 2022 Apr 5.
Multiple questions about SARS-CoV-2 humoral and cellular immunity remain unanswered. One key question is whether preexisting memory T or B cells, specific for related coronaviruses in SARS-CoV-2-unexposed individuals, can recognize and suppress COVID-19, but this issue remains unclear. Here, we demonstrate that antibody responses to SARS-CoV-2 antigens are restricted to serum samples from COVID-19 convalescent individuals. In contrast, cross-reactive T cell proliferation and IFN-γ production responses were detected in PBMCs of around 30% of donor samples collected prepandemic, although we found that these prepandemic T cell responses only elicited weak cT activation upon stimulation with either HCoV-OC43 or SARS-CoV-2 NP protein. Overall, these observations confirm that T cell cross-reactive with SARS-CoV-2 antigens are present in unexposed people, but suggest that the T cell response to HCoV-OC43 could be deficient in some important aspects, like T expansion, that might compromise the generation of cross-reactive T cells and antibodies. Understanding these differences in cellular responses may be of critical importance to advance in our knowledge of immunity against SARS-CoV-2.
关于 SARS-CoV-2 的体液和细胞免疫,仍有许多问题尚未得到解答。一个关键问题是,针对 SARS-CoV-2 未暴露个体中相关冠状病毒的预先存在的记忆 T 或 B 细胞,是否能够识别和抑制 COVID-19,但这个问题仍不清楚。在这里,我们证明了针对 SARS-CoV-2 抗原的抗体反应仅限于 COVID-19 恢复期个体的血清样本。相比之下,在大流行前采集的供体样本中约 30%的 PBMC 中检测到了交叉反应性 T 细胞增殖和 IFN-γ 产生反应,尽管我们发现这些大流行前 T 细胞反应仅在受到 HCoV-OC43 或 SARS-CoV-2 NP 蛋白刺激时才引发微弱的 cT 激活。总体而言,这些观察结果证实了未暴露人群中存在与 SARS-CoV-2 抗原交叉反应的 T 细胞,但表明针对 HCoV-OC43 的 T 细胞反应在某些重要方面可能存在缺陷,例如 T 细胞扩增,这可能会影响交叉反应性 T 细胞和抗体的产生。了解这些细胞反应的差异对于深入了解针对 SARS-CoV-2 的免疫可能至关重要。